Ontology highlight
ABSTRACT: Introduction
Reference intervals (RIs) for complement assays in EDTA plasma samples have not previously been published. The objectives of the present study were to validate and/or determine RIs for classical pathway (CP50) activity and C3c, C4 and C1 inhibitor protein (C1INH) assays and to assess the need for age-specific RIs in EDTA plasma.Materials and methods
We retrospectively evaluated a cohort of 387 patients attending our university hospital and known to be free of complement-modifying diseases. The need for age partitioning was assessed and RIs were calculated according to the CLSI protocol.Results
No need for age partitioning was evidenced for CP50 activity, C3c and C4 concentrations and RIs (90% CI) were calculated from the pooled data: 35.4 (33.1-37.2) to 76.3 (73.7-83.6) U/mL for CP50 activity, 0.80 (0.75-0.87) to 1.64 (1.59-1.72) g/L for C3c, and 0.12 (0.10-0.14) to 0.38 (0.36-0.40) g/L for C4. Our results highlight a positive association between age and C1INH concentrations. We derived 3 age partitions (6 months to 30 years, 30-50 and > 50 years) and the related RIs: 0.20 (0.18-0.21) to 0.38 (0.36-0.40) g/L, 0.22 (0.20-0.24) to 0.39 (0.36-0.41) g/L and 0.25 (0.22-0.27) to 0.41 (0.40-0.43) g/L, respectively).Conclusions
The newly determined RIs for CP50 activity were higher than those provided by the manufacturer for EDTA plasma samples, whereas those for C3c and C4 RIs were similar to the values provided for serum samples. The C1INH concentration and activity were found to be associated with age and age-specific RIs are mandatory for this analyte.
SUBMITTER: Lopez B
PROVIDER: S-EPMC6784422 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
Lopez Benjamin B Bertier Nicolas N Ledoult Emmanuel E Joudinaud Romane R Maanaoui Mehdi M Majerus Victoria V Moitrot Emmanuelle E Deleplancque Anne-Sophie AS Rogeau Stéphanie S Launay David D Lefèvre Guillaume G Labalette Myriam M Dubucquoi Sylvain S
Biochemia medica 20191001 3
<h4>Introduction</h4>Reference intervals (RIs) for complement assays in EDTA plasma samples have not previously been published. The objectives of the present study were to validate and/or determine RIs for classical pathway (CP50) activity and C3c, C4 and C1 inhibitor protein (C1INH) assays and to assess the need for age-specific RIs in EDTA plasma.<h4>Materials and methods</h4>We retrospectively evaluated a cohort of 387 patients attending our university hospital and known to be free of complem ...[more]